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A subclone of rat pheochromocytoma cells expresses high affinity receptors for tetanus toxin on differentiation with NGF [Walton, K.M., Sandberg, 
K., Rogers, T.B. and Schnaar, R.L. (1988) J. Biol. Chem. 263,2055-20631. In the presence of protein cross-linking agents, [‘*‘l]tetanus toxin, bound 
to these cells at O’C, forms a cross-linked product with apparent molecular weight of 120 kDa. The formation of [‘*‘I]tetanus toxin conjugate 
involves the heavy chain of the toxin, is prevented by cold toxin and it is largely reduced by pretreating cells with proteases. The cross-linked product 
is formed only upon incubation of the toxin with NGF-differentiated cells. These results suggest hat a protein with apparent molecular weight 
of 20 kDa is involved in the neurospecific binding of tetanus toxin. 
Tetanus toxin; Protein receptor; Pheochromocytoma cell; Naive growth factor; Cross-linker 
1. INTRODUCTION been hampered by the lack of cell lines sensitive to 
tetanus toxin suitable for biochemical investigations. 
Tetanus toxin induces the spastic paralysis of tetanus 
by blocking neurotransmilter release at the spinal cord 
inhibitory inteneurons [l]. Pn most mammals the LD,, 
of tetanus toxin is in the range 1-S ng/kg and this ex- 
treme potency is due, at least in part, to a very specific 
binding to neuronal cells [l]. 
Tetanus toxin (150 kDa) is composed of a heavy 
chain (100 kDa) and a light chain (50 kDa) held to- 
gether by a single disulfide bridge and by non-covalent 
forces [l]. There is evidence that the intracellular activ- 
ity of the toxin resides in the light chain while the heavy 
chain is responsible for cell binding and membrane tran- 
slocation [2,3j.. 
Recently a NGF-differentiated sub-clone of the rat 
phenochromocytoma cell line (PC 12) with high affinity 
tetanus toxin binding sites and inhibition of catechola- 
mine release was described [16,25]. Here we present the 
results of experiments performed with chemical cross- 
linking agents that provide a first direct evidence of the 
interaction of tetanus toxin with a receptor protein at 
the surface of a neuronal cell line. 
2. EXPERIMENTAL 
2.1. Mareriufs 
Despite efforts begun nearly one hundred years ago, 
the nature of the neurospecific receptor of tetanus toxin 
is still unknown [4,5]. The toxin was shown to bind to 
negatively charged lipids, particularly to polysialogan- 
gliosides, and treatment with neuraminidase decreases 
toxin binding to cells [6-201. On the other hand, the 
sensitivity to proteases of tetanus toxin binding to cells 
and neuronal membranes suggests that a protein com- 
ponent is involved [21-241. Research on this issue has 
Abbrevi~~tions: PC 12 cells, rat pheochromocytoma cell line; NGF, 
nerve growth factor; DSS, disuccinimidyl suberate; DSP, dithioDis- 
(succinimidylpropionate); BSOCOES, &s-2- (succinimido- 
oxycarbonyloxy)ethyl sulfone; HBS, Hanks Balanced Solution 
supplemented with I. 1 s/l glucose; PMSF, phenylmethylsulfonyl 
fluoride; TPCK, ,I-tosyl-L-phenylalanine chloromethyl ketone. 
Tetanus toxin was purified as detailed before [26] and stored at 
-80°C in i0 mivi Iiepes-Na, 5!! mM sodium chloride, PI-I 7.2. [‘ZSI]Te- 
tanus toxin was prepared with the Bolton-Hunter reagent (Amersham, 
U.K.) to a specific activity ofabout 3.5 mCi/mg with a residual toxicity 
higher than 85%. Disuccinimidyl suberate (DSS), dithiobis- 
(succinimidylpropionatc) (DSP) and Dis-2-(succinimidooxycarbonyl- 
oxy)ethyl sulfone (BSOCOES) were from Pierce (Oud Beijcrland, The 
Netherlands). TPCK treated-trypsin, a-chymotrypsin and octyl glu- 
coside were from Bochringer (Mannheim, Germany) and pronase 
from Calbiochem (San Diego, USA). PMSF, iodoacetamide, benza- 
midine, TPCK, o-phenantroline and Cfostridim pcrfiinyens neura- 
minidase were from Sigma (St. Louis, MO, USA). Antiserum anti- 
tetanus toxin was raised by immunizing New Zealand white rabbits 
with tetanus toxoid (Sclavo, Siena, Italy) following the procedure of 
Vaitukaitis [27]. Antisera versus the light chain and the heavy chain 
of tetanus toxin were obtained by immunizing rabbits with the isolated 
chains purified as described [28]. The immuno8lobulin fraction was 
isolated and affinity purified using the immobilized antigen as de- 
scribed previously [29]. 
Correspondence address: C. Montecucco, Istituto di Patologia Gene- 
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2.2. Cells and cell cullures 
The PC 12 subclone described in [16,25] was generously provided 
by Dr. T.R. Rogers (University of Maryland School of Medicine) and 
Published by Elsevier Science Publishers 8. V. 227 
Vohune 290, number 1,2 FEBS LETTERS September 199 1 
Dr. L. Rosenthal (Istituto Scientific0 San Raffaele, Milan) and was 
cultured according to the method described by Greene et al. [30]. 
Briefly, cells were grown at 37°C on plastic dishes (100 or 2.4 mm 
diameter) coated with collagen as described [l6]. Cells were cultured 
in Dulbecco’s modified Eagle’s medium (Flow, UK; supplemented 
with 44 mM sodium bicarbonate), 7.5% horse serum and 7.5% fetal 
calf serum, pH 7.4 in a humidified atmosphere of 5% CO, in air. 
Weekly subcultures were performed with initial cell density of 0.5-I 
million ceils per 100 mm diameter dish. Experiments were performed 
on cells seeded on 24 mm dishes (20 000 sells per dish) and differentia- 
ted with 50 @ml of NGF extracted from mouse submammillary 
glands as described [31]. 
2.3. Tetanus toxin cell binding umd cross-linking 
Cells, treated or not treated with NGF, were cooled on ice, washed 
with cold NBS, pH 7.5, and incubated with [12’I]tetanus toxin (0.5-l 
nM) for 2 h at 0°C. The procedure for cross-linking is adapted from 
previous work [32-371. Briefly, after two washings with cold HIPS, cells 
were treated with DSS or BSOCOES or DSP dissolved in HBS (200 
p&/ml from IO mdml stock solutions in dry freshly distilled DMSO) 
at 0°C foe 20 min. The medium was removed and replaced with HBS 
containing 20 mM glycine-NaOH, pH 7.5 for 5 min. Cells were 
washed two times with HBS and dissolved in I ml of FIBS con- 
taining 0.4% octyl glucoside, 1 mbf iodoacetamide, I mM benza- 
midine, 0.1 mM PMSF, 0.1 mM o-phenantroline. and IOpM TPCK. 
The samples were centrifuged in a refrigerated table centriFuge for 5 
min and supernatants were made 6.5% in trichloroacetic acid. Pellets 
were recovered by centrifugation ,and dissolved in 8% SDS, 10 mM 
Tris-acetate, 0.1 mM EDTA, pH 6.8, containing 5% 2-mercnptoe- 
thanol. Samples were boiled for 2 min and analyzed by sodium dode- 
cylsulfate gel electrophoresis on a discontinous system (6-126 polya- 
crylamide gradient) according to [38]. After Coomassie Blue staining, 
gels were dried and exposed to Kodak X-Omat films at -8O“C. The 
films were scanned with a dual wavelength densitometer (Shimadzu 
cs-930). 
In someexperiments, before incubation with [“‘Iltetanus toxin, cells 
were treated with pronase (I-lO,&$ml) or with neuraminidase (Z-50 
mu/ml) in HBS for 30 min at 37°C or with a mixture of trypsin (0.5 
mg/ml) and chymotrypsin (0.5 mg/ml) in HBS for 6 min at 37°C. After 
two washings with I ml of cold HBS, cells were incubated with HBS 
containing protcase inhibitors for 5 min at 0°C and then treated with 
BSOCOES as described above. Cells were counted on lysates by using 
4’,6-diamidine-2’-phenylindole dihydrochloride (DAPI; Boehringer, 
Mannheim, Germany) [39]. Briefly, 5 ~1 of cell lysates were mixed with 
I.5 ml of IO mM Tris-HCI, IO mM EDTA, 100 mM sodium chloride, 
0.05% Triton X-100, 100 @ml DAPI, pH 7.0, and fluorescence was 
measured. 
2.4. Immunoblotting 
After tetanus toxin binding and cross-linking, cells were solubilized 
as described above and treated with affinity purified rabbit immuno- 
globulins anti-tetanus toxin. The mixture was incubated for 2 hat 4OC 
and 200 ~1 of 10% Protein A-Sephdrose (Phnrmacia, Uppsala, Swe- 
den) was added and incubation prolonged for additional 2 h. The 
pellet was collected by centrifugation, washed twice with HBS con- 
taining 0.4% octyl glucoside, solubilized and electrophoresed as above. 
Proteins were transferred onto nitrocellulose, incubated with affinity- 
purified rabbit immunoglobulins anti either the !i,&t chain or the 
heavy chain of tetanus toxin and stained with goat anti-rabbit IgG 
antibodies conjugated with alkaline phosphatase (Boehringer, Mann- 
heim, Germany) as described [40]. 
3. RESULTS AND DISCUSSION 
The cellular structures involved in the neurospecific 
high aflinity cell binding of tetanus toxin are still unde- 
termined. Both polysialogangliosides and protein have 
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Fig. I. Cross-linking of [‘zsI]tetanus toxin to PC-12 cells. Cells from 
a PC-12 subolone [I61 (lanes l-5 and 7)orPC-12cells (301 (lane 8) were 
cultured in the presence (lanes l-5 and 8) or in the absence (lane 7) 
oTNGF (50 @ml) for I5 days. After washing, the cells were incubated 
at 0°C with [‘z51]tetanus toxin (0.5-l nM) for 2 h; the sample of lane 
5 contained a 300-fold excess of cold toxin. After washing, cross- 
linkers were added: none in the sample of lane I, DSS (lane 3); BSO- 
COES (lanes 2, 5-8), DSP (lane 4). Lane 6 refers to [“SI]tetanus toxin 
incubated in the absence ofcells and treated with BSOCOES as above. 
Proteins were electrophoresed under reducing conditions and, after 
Coomassie Blue staining, gels were dried and exposed to Kodak X- 
Omat films at -8OOC. The two major radioactive bands represent he 
heavy (100 kDa) and the light chains (50 kDa) of tetanus toxin and 
the bands at apparent molecular weight I50 kDa and larger are due 
to cross-linking of the toxin chains among themselves. P, indicates a 
protein band with apparent M,, I20 kDa which is formed uniquely in 
the presence of non-cleavablecross-linkers when the [‘2SI]tetanus toxin 
is incubated with the PC-12 subclone after differentiation with NGF. 
been proposed to play a receptor role [2-51. Recently a 
subclone of the PC-12 cell line was shown to bind teta- 
nus toxin with consequent inhibition of catecholamine 
release after differentiation with NGF [16,253. The in- 
duction of neurite growth by NGF on this subclone is 
apparent already after two days and an extensive neuro- 
nal network is established within one week (not shown). 
Chemical cross-linkers have been used successfully in 
the identification of the cell surface protein receptors of 
hormones, growth factors and diphtheria toxin [32-371. 
Were we have used three homofunctional protein cross- 
linkers: DSP, DSS and BSOCOES (differing for solubi- 
lity properties and cleavability by reducing agents) to 
investigate the possible involvement of a protein in the 
binding of tetanus toxin to the PC-12 subclone de- 
scribed above. 
Cells were incubated with [‘Z51]tetanus toxin in the 
cold and, after washing, cross-linker was added under 
a variety of conditions. Cell proteins were recovered 
and subjected to SDS-PAGE in the presence of reducing 
agents, Fig. 1 shows that in the presence of DSS and 
BSOCOES (lanes 2 and 3) new radioactive bands are 
formed. A set of bands of apparent M, 150 kDa and 
larger derive from cross-linking of the toxin heavy and 
light chains among themselves since t,hey also occur 
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Fig. 2. Immunoblotting of tetanus toxin after binding and cross- 
linking to PC-I2 cells. Lane 1 is an autoradiographic image of a sample 
treated as in lane 3 of Fig. I. Lanes 2 and 4 refer to NGF-differentiated 
PC-12 subclone cells incubated with tetanus toxin and BSCXOES, 
dissolved and immunoprecipitated with an affinity-purified rabbit 
anti-tetanus toxin antiserum and Protein A-Sepharose, The sample 
was electrophoresed, electroblotted on nitrocellulose and immuno- 
stained with affinity-purified rabbit anti-tetanus toxin heavy chain 
antiserum (lane 2; lane 3 is a control of 50 ng of tetanus toxin) or anti 
light chain (lane 4; lane 5 is a control of 50 ng of tetanus toxin) and 
goat anti-rabbit IgG antiserum conjugated with alkaline 
phosphatases. Staining in the lower part of lanes 2 and 4 is related to 
the rabbit immunoglobulins used foe immunoprecipitation. 
with the toxin alone (lane 6). The only band which 
appears uniquely upon cell incubation has an apparent 
M, of 120 kDa, as deduced from its migration with 
respect to protein standards. This band is absent if DSP, 
a cross-linker cleaved by reduction, is used (lane 4) or 
in the absence of cross-linker (lane 1) or in the presence 
of an excess of cold toxin (lane 5). Fig. 1 also shows that 
the tetanus toxin binding protein is virtually absent in 
the undifferentiated cells of the PC-12 subclone (lane 7) 
and also in the NGF-differentiated PC-12 cells estab- 
lished by Greene et al. (lane 8) [30]. 
The amount of cross-linked conjugate is low and this 
correlates with the low number of high affinity binding 
sites evidenced by binding studies [16]. For this reason 
it is not immediately apparelit which of the two toxin 
subunits is involved in the formation of the cross-linked 
product. From densitometric scanning, it appears that 
upon cross-linking there is no decrease of the light chain 
b:ind, rather there is a decrease of the ratio heavy chain 
over light chain thus suggesting an involvement of the 
heavy chain of the toxin. To substantiate this point, 
tetanus toxin, after binding and cross-linking to WGF- 
differentiated cells, was immunopTccipitated with affin- 
ity purified rabbit anti-tetanus toxin immunoglobulins. 
Fig. 2 shows that the 120 kDa that appears upon cross- 
linking is stained by affinity-purified anti-tetanus toxin 
Table I 
Effect of proteases and neuraminidase treatment on the amount of 120 
kDa [‘ZJl]tetanus toxin-conjugate and on the total [‘2JI]tetanus toxin 
bound to PC-12 cells 
A B 
PC- I2 subclone cells 100% 100% 
Cetls + pronase 35-40% 40-50% 
Cells + trypsin/chymotrypsin 6S-40% 55-65% 
Cells f neuraminidase 95-1058 IS-85% 
The amount ofcross-linked product (column A) and the total radiodc- 
tivity bound to cells (column B) are expressed as percentage of the 
corresponding amount found in the absence of pretreatments taken 
as 100%. 
heavy chain immunoglobulins and not by anti light 
chain immunoglobulins. These findings are in agree- 
ment with studies indicating that the heavy chain of 
tetanus toxin is involved in cell binding [41-43] in ana- 
logy to the closely related botulinum neurotoxins [44- 
463. 
These results indicate that, upon binding to the cell 
surface of this neuronal cell line, tetanus toxin interacts 
specifically and closely with a protein via its heavy 
chain. If a cross-linker is present, a covalent conjugate 
of about 120 kDa is formed. The apparent molecular 
weight of the toxic binding protein is 20 kE)a, deduced 
from the difference between the migration in SDS- 
PAGE of the conjugate and that of the toxin heavy 
chain. 
Previous studies have shown that the binding of teta- 
nus toxin to neuronal cells in culture and to neuronal 
membranes is sensitive to trypsin, chymotrypsin and 
pronase and also to neuraminidase [10,22-243. It is not 
clear, however, if the effect of these enzymes is due to 
a direct effect on a proteinic sialylated receptor or to a 
indirect perturbative effect on other membrane compo- 
nents. Table I shows that proteases largely decrease the 
amount of tetanus toxin cross-linked product thus indi- 
cating that a binding component of tetanus toxin on 
NGF-differentiated PC-12 cells is indeed a protein. 
Treatment with neuraminidase does not influence the 
amount of tetanus toxin conjugate while it does reduce 
the total amount of toxin bound to cells. This result 
suggests that at least part of the toxin binding to these 
cells is mediated by polysialogangliosides. 
In conclusion, this stud;; presents compelling evi- 
dence that a 20 kDa protein is involved in the binding 
of tetanus toxin via its heavy c;hain to a neuronal cell 
line in culture differentiated with NGF. Together with 
the demonstration that tetanus toxin binds to negatively 
charged lipids [6-201, the present findings are in favour 
of a double receptor model for the binding of tetanus 
toxin to neuronal cells [2,3,5] and correlate with the 
results obtained from physiological studies on Apfysiu 
neurons [41,45,46]. 
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